BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 34758415)

  • 1. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
    O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
    EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
    O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
    bioRxiv; 2021 Jul; ():. PubMed ID: 34268506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines-A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters.
    Trimpert J; Herwig S; Stein J; Vladimirova D; Adler JM; Abdelgawad A; Firsching TC; Thoma T; Sehouli J; Osterrieder K; Gruber AD; Sawitzki B; Sander LE; Cichon G
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
    Brustolin M; Rodon J; Rodríguez de la Concepción ML; Ávila-Nieto C; Cantero G; Pérez M; Te N; Noguera-Julián M; Guallar V; Valencia A; Roca N; Izquierdo-Useros N; Blanco J; Clotet B; Bensaid A; Carrillo J; Vergara-Alert J; Segalés J
    Emerg Microbes Infect; 2021 Dec; 10(1):797-809. PubMed ID: 33825619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.
    Carroll T; Fox D; van Doremalen N; Ball E; Morris MK; Sotomayor-Gonzalez A; Servellita V; Rustagi A; Yinda CK; Fritts L; Port JR; Ma ZM; Holbrook MG; Schulz J; Blish CA; Hanson C; Chiu CY; Munster V; Stanley S; Miller CJ
    PLoS Pathog; 2022 Feb; 18(2):e1009914. PubMed ID: 35143587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.
    Chan JF; Zhang AJ; Yuan S; Poon VK; Chan CC; Lee AC; Chan WM; Fan Z; Tsoi HW; Wen L; Liang R; Cao J; Chen Y; Tang K; Luo C; Cai JP; Kok KH; Chu H; Chan KH; Sridhar S; Chen Z; Chen H; To KK; Yuen KY
    Clin Infect Dis; 2020 Dec; 71(9):2428-2446. PubMed ID: 32215622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
    Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM
    mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.
    Rosenke K; Meade-White K; Letko M; Clancy C; Hansen F; Liu Y; Okumura A; Tang-Huau TL; Li R; Saturday G; Feldmann F; Scott D; Wang Z; Munster V; Jarvis MA; Feldmann H
    Emerg Microbes Infect; 2020 Dec; 9(1):2673-2684. PubMed ID: 33251966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine.
    Hawman DW; Meade-White K; Clancy C; Archer J; Hinkley T; Leventhal SS; Rao D; Stamper A; Lewis M; Rosenke R; Krieger K; Randall S; Khandhar AP; Hao L; Hsiang TY; Greninger AL; Gale M; Berglund P; Fuller DH; Rosenke K; Feldmann H; Erasmus JH
    EBioMedicine; 2022 Sep; 83():104196. PubMed ID: 35932641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.
    Stauft CB; Lien CZ; Selvaraj P; Liu S; Wang TT
    Virology; 2021 Apr; 556():96-100. PubMed ID: 33556653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.
    Sia SF; Yan LM; Chin AWH; Fung K; Choy KT; Wong AYL; Kaewpreedee P; Perera RAPM; Poon LLM; Nicholls JM; Peiris M; Yen HL
    Nature; 2020 Jul; 583(7818):834-838. PubMed ID: 32408338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7.
    Fischer RJ; van Doremalen N; Adney DR; Yinda CK; Port JR; Holbrook MG; Schulz JE; Williamson BN; Thomas T; Barbian K; Anzick SL; Ricklefs S; Smith BJ; Long D; Martens C; Saturday G; de Wit E; Gilbert SC; Lambe T; Munster VJ
    Nat Commun; 2021 Oct; 12(1):5868. PubMed ID: 34620866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
    Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
    Front Immunol; 2022; 13():811430. PubMed ID: 35250984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.
    Darling TL; Ying B; Whitener B; VanBlargan LA; Bricker TL; Liang CY; Joshi A; Bamunuarachchi G; Seehra K; Schmitz AJ; Halfmann PJ; Kawaoka Y; Elbashir SM; Edwards DK; Thackray LB; Diamond MS; Boon ACM
    Med; 2022 May; 3(5):309-324.e6. PubMed ID: 35584653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
    Imai M; Iwatsuki-Horimoto K; Hatta M; Loeber S; Halfmann PJ; Nakajima N; Watanabe T; Ujie M; Takahashi K; Ito M; Yamada S; Fan S; Chiba S; Kuroda M; Guan L; Takada K; Armbrust T; Balogh A; Furusawa Y; Okuda M; Ueki H; Yasuhara A; Sakai-Tagawa Y; Lopes TJS; Kiso M; Yamayoshi S; Kinoshita N; Ohmagari N; Hattori SI; Takeda M; Mitsuya H; Krammer F; Suzuki T; Kawaoka Y
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16587-16595. PubMed ID: 32571934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
    Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
    Front Immunol; 2021; 12():747830. PubMed ID: 34858404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters.
    Lee AC; Zhang AJ; Chan JF; Li C; Fan Z; Liu F; Chen Y; Liang R; Sridhar S; Cai JP; Poon VK; Chan CC; To KK; Yuan S; Zhou J; Chu H; Yuen KY
    Cell Rep Med; 2020 Oct; 1(7):100121. PubMed ID: 32984855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.